tirzepatide kidneys kidney issues with Protecting is a crucial part of managing Type 2 Diabetes. Recent Tirzepatide for Weight Loss with

doi:10.1093/bmb/ldy035

Protocol 4: Post-menopausal metabolic restoration Goal: Address menopausal weight gain and metabolic changes Stack: Tirzepatide: Standard protocol (addresses insulin resistance) Tesamorelin: 1-2mg daily (visceral fat) CJC-1295/Ipamorelin: 200mcg each before bed (body composition, bone density) Resistance training: 3-4x per week Adequate protein and calcium Duration: 12+ months, potentially ongoing Expected results: 25-45 pounds weight loss Reduced visceral fat Improved insulin sensitivity Better body composition Maintained bone density Why this works: Addresses multiple menopausal factors - insulin resistance, visceral fat, muscle loss, bone density

However, if youve been prescribed Mounjaro via the NHS, current NICE guidelines dont recommend using it beyond 2 years

November 2025: Researchers at Mass General Brigham are trying to understand how semaglutide drugs like Rybelsus might lead to vision loss